Protocol Ledger

NCT04797013 · Phase III · COMPLETED

Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ

Interventional Phase III clinical trial protocol NCT04797013 sponsored by Beijing Tiantan Hospital in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-06-12 Enrollment: 1,430 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04797013
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,430 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04797013
Protocol FieldVerified Registry Value
NCT IdentifierNCT04797013
Consolidated Lead SponsorBeijing Tiantan Hospital
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment1,430 participants (ACTUAL)
Registered Start Date2021-06-12
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04797013
Hospital Research SiteLocationSite Profile
Beijing Tiantan Hospital, Capital Medical UniversityBeijing, ChinaOpen Hospital Dossier ->
The First Hospital of Lanzhou UniversityLanzhou, ChinaOpen Hospital Dossier ->
The First Hospital of Hebei Medical UniversityShijiazhuang, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI